Old Web
English
Sign In
Acemap
>
authorDetail
>
Takashi Miki
Takashi Miki
Astellas Pharma
Fidaxomicin
Internal medicine
clostridium difficile
Clostridium
Clostridioides
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[Antimicrobial profile and clinical evidence of fidaxomicin (Dafclir®), a therapeutic agent for Clostridioides (Clostridium) difficile infection].
2019
Folia Pharmacologica Japonica
Shinobu Takeda
Takashi Miki
Show All
Source
Cite
Save
Citations (0)
Antimicrobial susceptibility and molecular characterisation using whole-genome sequencing of Clostridioides difficile collected in 82 hospitals in Japan between 2014 and 2016
2019
Antimicrobial Agents and Chemotherapy
Kotaro Aoki
Shinobu Takeda
Takashi Miki
Yoshikazu Ishii
Kazuhiro Tateda
Show All
Source
Cite
Save
Citations (7)
Efficacy and safety of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in a randomized, double-blind, comparative Phase III study in Japan
2018
Journal of Infection and Chemotherapy
Hiroshige Mikamo
Kazuhiro Tateda
Katsunori Yanagihara
Shinya Kusachi
Yoshio Takesue
Takashi Miki
Yuki Oizumi
Kazuaki Gamo
Atsuki Hashimoto
Junko Toyoshima
Kenichi Kato
Show All
Source
Cite
Save
Citations (20)
Comparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjects.
2015
Clinical Drug Investigation
Hiroyuki Oshima
Takao Yamazaki
Lauren Benner
Takashi Miki
Ingrid N Michon
Tomasz Wojtkowski
Atsunori Kaibara
Salim Mujais
Show All
Source
Cite
Save
Citations (7)
1